Echo Therapeutics
Durham
North Carolina
United States
223 articles about Echo Therapeutics
-
Echo Therapeutics Raises $7.5 Million In Funding For Manufacturing And Product Expansion
3/31/2017
-
Echo Therapeutics Announces Dismissal Of Federal Court Action
12/21/2016
-
Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
12/13/2016
-
Echo Therapeutics Announces Second Quarter 2016 Financial Results
8/15/2016
-
New Jersey's Echo Therapeutics Delisted from Nasdaq, Shares Plummet
7/13/2016
-
Echo Therapeutics Common Stock To Transition From NASDAQ To OTCQB
7/11/2016
-
Echo Therapeutics Begins Testing Of NextGen CGM System Components
6/29/2016
-
Echo Therapeutics Announces New Patent For Its Non-Invasive Sensing Technology
6/22/2016
-
Echo Therapeutics Announces Institutional Review Board (IRB) Approval Of New Protocol
6/13/2016
-
Echo Therapeutics In Final Stage Of Clinical Research Organization (CRO) Selection
6/2/2016
-
Echo Therapeutics Announces First Quarter 2016 Financial Results
5/23/2016
-
Echo Therapeutics Announces Successful Software Transfer To Its Strategic Partner, MTIA
5/17/2016
-
Echo Therapeutics Announces Final Closing Of Private Placement Of $5.1 Million Of Convertible Notes And Warrants
5/5/2016
-
Echo Therapeutics Announces Significant Progress In Key Development Milestones
5/3/2016
-
Echo Therapeutics Announces Conference Call To Provide An Update On Corporate Milestones
4/28/2016
-
Echo Therapeutics Announces Voting Results Of Special Meeting Of Stockholders
4/15/2016
-
Echo Therapeutics Announces 2015 Financial Results
3/31/2016
-
Echo Therapeutics Announces New Patents for Non-Invasive Sensing Technology
2/22/2016
-
Echo Therapeutics Announces Conference Call And Webcast To Provide A Corporate Update
2/8/2016
-
Echo Therapeutics Announces Entry Into Definitive Agreements For The Sale Of Up To $5.1 Million Of Convertible Notes And Warrants
2/1/2016